Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F23%3A73617077" target="_blank" >RIV/61989592:15310/23:73617077 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61989592:15640/23:73617077
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S0223523422008947?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0223523422008947?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.ejmech.2022.114992" target="_blank" >10.1016/j.ejmech.2022.114992</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents
Popis výsledku v původním jazyce
Two cationic [Cu-2(L1-2)(2)](ClO4)(2) (1, 2), and four neutral doubly bridged-phenoxido-copper(II) complexes [Cu-2(L3-4)(2)] (3, 4) and [Cu-2(L5-6)(2)(H2O)center dot 2H(2)O (5, 6) as well as 1D polymeric catena-[Cu(L-7)] (7), where HL1-2 and H2L3-7 represent tripodal tetradentate pyridyl or aliphatic-amino groups based 2,4-disubstituted phenolates, were synthesized and thoroughly characterized by various spectroscopic methods and single crystal X-ray analysis. The molecular structures of the complexes exhibited diverse geometrical environments around the central Cu(II) atoms. The in vitro antiproliferative activity of the isolated complexes and selected parent free ligands were screened against some human cancer cell lines (A2780, A2780R, PC-3, 22Rv1, MCF-7). The most promising cytotoxicity against cancer cells were obtained for 1-6, while complex 6 was found as the best per-forming as compared to the reference drug cisplatin. The cytotoxicity study of complex 6 was therefore extended to wider variety of cancer cell lines (HOS, A549, PANC-1, CaCo2, HeLa) and results revealed its significant cytotoxicity on all investigated human cancer cells. The cell uptake study showed that cytotoxicity of 6 (3 mu M concentration and 24 h of incubation) against A2780 cells was almost independent from the intracellular levels of copper. The effect of complexes 4, 6 and 7 on cell cycle of A2780 cells indicates that the mechanism of action in these complexes is not only different from that of cisplatin but also different among them. Complex 7 was able to induce apoptosis in A2780 cells, while complexes 4 and 6 did not and on the other hand, they showed considerable effect on autophagy induction and there are some clues that these complexes were able to induce cuproptosis in A2780 cells.
Název v anglickém jazyce
Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents
Popis výsledku anglicky
Two cationic [Cu-2(L1-2)(2)](ClO4)(2) (1, 2), and four neutral doubly bridged-phenoxido-copper(II) complexes [Cu-2(L3-4)(2)] (3, 4) and [Cu-2(L5-6)(2)(H2O)center dot 2H(2)O (5, 6) as well as 1D polymeric catena-[Cu(L-7)] (7), where HL1-2 and H2L3-7 represent tripodal tetradentate pyridyl or aliphatic-amino groups based 2,4-disubstituted phenolates, were synthesized and thoroughly characterized by various spectroscopic methods and single crystal X-ray analysis. The molecular structures of the complexes exhibited diverse geometrical environments around the central Cu(II) atoms. The in vitro antiproliferative activity of the isolated complexes and selected parent free ligands were screened against some human cancer cell lines (A2780, A2780R, PC-3, 22Rv1, MCF-7). The most promising cytotoxicity against cancer cells were obtained for 1-6, while complex 6 was found as the best per-forming as compared to the reference drug cisplatin. The cytotoxicity study of complex 6 was therefore extended to wider variety of cancer cell lines (HOS, A549, PANC-1, CaCo2, HeLa) and results revealed its significant cytotoxicity on all investigated human cancer cells. The cell uptake study showed that cytotoxicity of 6 (3 mu M concentration and 24 h of incubation) against A2780 cells was almost independent from the intracellular levels of copper. The effect of complexes 4, 6 and 7 on cell cycle of A2780 cells indicates that the mechanism of action in these complexes is not only different from that of cisplatin but also different among them. Complex 7 was able to induce apoptosis in A2780 cells, while complexes 4 and 6 did not and on the other hand, they showed considerable effect on autophagy induction and there are some clues that these complexes were able to induce cuproptosis in A2780 cells.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10402 - Inorganic and nuclear chemistry
Návaznosti výsledku
Projekt
<a href="/cs/project/EF16_019%2F0000754" target="_blank" >EF16_019/0000754: Nanotechnologie pro budoucnost</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
ISSN
0223-5234
e-ISSN
1768-3254
Svazek periodika
246
Číslo periodika v rámci svazku
January
Stát vydavatele periodika
FR - Francouzská republika
Počet stran výsledku
13
Strana od-do
—
Kód UT WoS článku
000902003000005
EID výsledku v databázi Scopus
2-s2.0-85144060026